Form 483

LNK International, Inc. Form 483, 2015-01-30

FDA issued a Form 483 to LNK International, Inc. on 2015-01-30 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

LNK International, Inc. · Hauppauge, United States · Issued January 30, 2015

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Jan 2015
21 CFR 211.101(b)

Measured components for manufacturing

Cited by Samina S Khan, Patric C Klotzbuecher, Philip F Istafanos

30 Jan 2015
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Samina S Khan, Patric C Klotzbuecher, Philip F Istafanos

30 Jan 2015
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Samina S Khan, Patric C Klotzbuecher, Philip F Istafanos

30 Jan 2015
21 CFR 211.198(b)(2)

Complaint Investigation/Follow-Up Findings

Cited by Samina S Khan, Patric C Klotzbuecher, Philip F Istafanos

30 Jan 2015
21 CFR 211.67(b)

Written procedures fail to include

Cited by Samina S Khan, Patric C Klotzbuecher, Philip F Istafanos

Inspected site

LILNK International, Inc.Hauppauge, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.101(b)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere